Fredun Pharmaceuticals Ltd reports Q2 FY27 total income of ₹267.64 crore, up 84.21% YoY
- Q2 net profit rose 93.44% YoY to ₹18.83 crore; EBITDA margin was 15.92%, versus 15.37% a year earlier.
- H1 FY27 total income increased 87.02% YoY to ₹495.88 crore.
- H1 net profit rose 93.92% YoY to ₹31.99 crore; EBITDA margin was 15.20%, versus 14.83%.